{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:32:21Z","timestamp":1790994741001,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2024QH1009"],"award-info":[{"award-number":["2024QH1009"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bcp.2026.117843","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:38:45Z","timestamp":1771918725000},"page":"117843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cabozantinib inhibits necroptosis by targeting MLKL oligomerization and alleviates psoriasis in vivo"],"prefix":"10.1016","volume":"248","author":[{"given":"Rui","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuibing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaofa","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1317-0970","authenticated-orcid":false,"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bcp.2026.117843_b0005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/ni.2159","article-title":"Programmed necrosis: backup to and competitor with apoptosis in the immune system","volume":"12","author":"Han","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117843_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41419-024-06447-6","article-title":"LUBAC-mediated M1 Ub regulates necroptosis by segregating the cellular distribution of active MLKL","volume":"15","author":"Weinelt","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117843_b0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev-biochem-060815-014830","article-title":"Necroptosis and Inflammation","volume":"85","author":"Newton","year":"2016","journal-title":"Annu. Rev. Biochem"},{"issue":"6","key":"10.1016\/j.bcp.2026.117843_b0020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","article-title":"Necroptosis molecular mechanisms: recent findings regarding novel necroptosis regulators","volume":"53","author":"Seo","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117843_b0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.117843_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113925","article-title":"A Glimpse of necroptosis and diseases","volume":"156","author":"Yang","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bcp.2026.117843_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10281","key":"10.1016\/j.bcp.2026.117843_b0040","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.bcp.2026.117843_b0045","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"20","key":"10.1016\/j.bcp.2026.117843_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207488","article-title":"New treatment addressing the pathogenesis of psoriasis","volume":"21","author":"Tokuyama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.117843_b0055","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41419-021-04284-5","article-title":"Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation","volume":"12","author":"Shou","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.117843_b0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41419-020-2328-0","article-title":"Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation","volume":"11","author":"Duan","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bcp.2026.117843_b0065","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/cpt.1852","article-title":"Response to inhibition of receptor-interacting protein kinase 1 (RIPK1) in active plaque psoriasis: a randomized placebo-controlled study","volume":"108","author":"Weisel","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.117843_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109615","article-title":"Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models","volume":"121","author":"Jiang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117843_b0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcp.2016.02.001","article-title":"Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models","volume":"105","author":"Zhang","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117843_b0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/17425255.2019.1681969","article-title":"Pharmacodynamics OF TNF alpha inhibitors for the treatment of psoriasis","volume":"15","author":"Campanati","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117843_b0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117843_b0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","article-title":"RIP3 induces apoptosis independent of pronecrotic kinase activity","volume":"56","author":"Mandal","year":"2014","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.117843_b0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41419-024-06514-y","article-title":"Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.117843_b0100","doi-asserted-by":"crossref","first-page":"14329","DOI":"10.1038\/ncomms14329","article-title":"RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2026.117843_b0105","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/cdd.2014.70","article-title":"RIPK1- and RIPK3-induced cell death mode is determined by target availability","volume":"21","author":"Cook","year":"2014","journal-title":"Cell Death Differ."},{"issue":"668","key":"10.1016\/j.bcp.2026.117843_b0110","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abc6178","article-title":"Location, location, location: a compartmentalized view of TNF-induced necroptotic signaling","volume":"14","author":"Samson","year":"2021","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2026.117843_b0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ncb2883","article-title":"Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis","volume":"16","author":"Cai","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117843_b0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2026.117843_b0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molcel.2019.05.022","article-title":"TAM kinases promote necroptosis by regulating oligomerization of MLKL","volume":"75","author":"Najafov","year":"2019","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.117843_b0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/15548627.2020.1725381","article-title":"Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation","volume":"17","author":"Wang","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.bcp.2026.117843_b0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2217\/bmm-2020-0360","article-title":"Plasma heat shock protein 90 levels in patients with spondyloarthritis and their relation to structural changes: a cross-sectional study","volume":"15","author":"Bubova","year":"2021","journal-title":"Biomark. Med."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2026.117843_b0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"issue":"7631","key":"10.1016\/j.bcp.2026.117843_b0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nature20558","article-title":"RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation","volume":"540","author":"Lin","year":"2016","journal-title":"Nature"},{"issue":"7631","key":"10.1016\/j.bcp.2026.117843_b0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature20559","article-title":"RIPK1 inhibits ZBP1-driven necroptosis during development","volume":"540","author":"Newton","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2026.117843_b0155","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191913","article-title":"Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation","volume":"217","author":"Devos","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.117843_b0160","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/acs.jmedchem.7b01449","article-title":"Tozasertib analogues as inhibitors of necroptotic cell death","volume":"61","author":"Hofmans","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.117843_b0165","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s42003-023-05353-5","article-title":"Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis","volume":"6","author":"Huang","year":"2023","journal-title":"Commun. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117843_b0170","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.1038\/cddis.2014.241","article-title":"The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.117843_b0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/1673-5374.226394","article-title":"Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury","volume":"13","author":"Cruz","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"7788","key":"10.1016\/j.bcp.2026.117843_b0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","article-title":"A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1","volume":"577","author":"Tao","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2026.117843_b0185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.molcel.2020.11.008","article-title":"RIPK1 promotes energy sensing by the mTORC1 pathway","volume":"81","author":"Najafov","year":"2021","journal-title":"Mol. Cell"},{"issue":"42","key":"10.1016\/j.bcp.2026.117843_b0190","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1073\/pnas.1408987111","article-title":"Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death","volume":"111","author":"Hildebrand","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"26","key":"10.1016\/j.bcp.2026.117843_b0195","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1039\/C7CC00667E","article-title":"Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein","volume":"53","author":"Yan","year":"2017","journal-title":"Chem. Commun. (Camb)"},{"issue":"19","key":"10.1016\/j.bcp.2026.117843_b0200","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1021\/acs.jmedchem.2c00548","article-title":"Discovery of a new class of uracil derivatives as potential mixed lineage kinase domain-like protein (MLKL) inhibitors","volume":"65","author":"Cui","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117843_b0205","doi-asserted-by":"crossref","unstructured":"Belzutifan plus cabozantinib is effective in immunotherapy-treated renal cell carcinoma, Cancer Discovery 13(6) (2023) OF14-OF14.","DOI":"10.1158\/2159-8290.CD-RW2023-057"},{"issue":"4","key":"10.1016\/j.bcp.2026.117843_b0210","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41591-023-02275-x","article-title":"Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial","volume":"29","author":"Saba","year":"2023","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117843_b0215","article-title":"Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: phase Ib CAMILLA trial results","volume":"4","author":"Saeed","year":"2023","journal-title":"Cell Rep. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:17:52Z","timestamp":1778653072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S0006295226001747"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117843","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cabozantinib inhibits necroptosis by targeting MLKL oligomerization and alleviates psoriasis in vivo","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117843"}}